genitourinary tumours, non prostate Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ravaud, A; Motzer, RJ; Pandha, HS; Staehler, M; George, D; Pantuck, AJ; Patel, A; Chang, YH; Escudier, B; Donskov, F; Magheli, A; Carteni, G; Laguerre, B; Tomczak, P; Breza, J; Gerletti, P; Lin, X; Lechuga, M; Martini, JF; Patard, JJ

Published Date

  • October 1, 2016

Published In

Volume / Issue

  • 27 /

Start / End Page

  • vi565 -

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdw435.22

Citation Source

  • Scopus